⚠ Evidence warning: Clinical trials or other evidence do not support the claim that most clinicians in endemic areas give doxycycline plus a short prednisone taper for Lyme-associated facial palsy. This page keeps it as a report of what people, websites or other media say.

Lyme Neuroborreliosis — When Lyme Affects the Nervous System

Lyme Neuroborreliosis — scientific infographic poster

Table of Contents

  1. What Neuroborreliosis Is
  2. Cranial Neuropathy — The Most Common U.S. Presentation
  3. Lymphocytic Meningitis
  4. Painful Radiculoneuritis (Bannwarth Syndrome)
  5. Late-Stage Encephalomyelitis
  6. Lyme Encephalopathy
  7. Peripheral Neuropathy
  8. Diagnostic Workup
  9. When a Lumbar Puncture Is and Is Not Done
  10. Treatment — Intravenous vs Oral
  11. Bell's Palsy Specifically
  12. Recovery Timeline
  13. Residual Symptoms After Treatment
  14. Red Flags Requiring the ER
  15. Key Research Papers
  16. Connections
  17. Featured Videos

What Neuroborreliosis Is

Neuroborreliosis is what doctors call it when the Lyme disease bacterium, Borrelia burgdorferi (and its European cousins B. garinii and B. afzelii), crosses into the nervous system. The bug can slip past the blood-brain barrier within weeks of the tick bite, seed the cranial nerves, the meninges (the lining around the brain and spinal cord), and the nerve roots where they exit the spine. From there it sets off an inflammatory response that produces the specific patterns described below.

Roughly 10–15% of untreated U.S. Lyme patients develop some neurologic involvement, usually in the early-disseminated phase two to twelve weeks after the bite. In Europe the number is higher, because B. garinii is noticeably more neurotropic — it has a stronger affinity for nerve tissue — and roughly a third of European neuroborreliosis cases present with painful nerve-root inflammation, something rarely seen in North America.

Neurologic symptoms are frightening. A drooping face, a splitting headache that will not quit, shooting pains that wake you at 3 a.m. — these feel like a stroke, a tumor, or something permanent. The reassuring truth is that the vast majority of neuroborreliosis cases respond completely to a two-to-three-week course of antibiotics. This article walks through what each pattern looks like, how doctors sort them out, and what recovery realistically looks like.

Cranial Neuropathy — The Most Common U.S. Presentation

The single most common neurologic manifestation of Lyme in North America is facial nerve palsy — a Bell's palsy appearance caused by inflammation of cranial nerve VII. One side of the face droops: the eyelid won't close fully, the corner of the mouth sags, food collects in the cheek, and patients drool when they drink. Taste on the front two-thirds of the tongue may be blunted, and sounds can seem uncomfortably loud on the affected side.

Clinicians in endemic areas work by one well-known rule: bilateral facial palsy — both sides drooping at once or in quick succession — is Lyme disease until proven otherwise. Idiopathic Bell's palsy is almost always unilateral. Bilateral simultaneous palsy is so uncommon in non-Lyme settings that it forces a serology test and, often, empirical treatment before results return.

A United States series of 44 people with facial palsy from Lyme neuroborreliosis (Marques 2022) shows how this looks in practice: most fell ill in the summer months, 29 had the erythema migrans rash, 13 had palsy on both sides, usually one side after the other, and 14 also had painful nerve-root pain (radiculopathy).

Other cranial nerves can be affected, though much less often:

More than one cranial nerve can be involved at the same time. In endemic regions, clinicians commonly test for Lyme disease when any cranial neuropathy appears in summer or early fall, even without a remembered tick bite or rash.

Lymphocytic Meningitis

Lyme meningitis looks and feels like other viral meningitides: headache, neck stiffness, photophobia (light hurts the eyes), nausea, and mild fever. The key distinguishing feature from bacterial meningitis is time course. Bacterial meningitis hits in hours and makes patients desperately ill; Lyme meningitis smolders for days to weeks. Many patients describe a relentless headache that started quietly and just refused to quit, not the thunderclap onset of a true medical emergency.

On lumbar puncture the cerebrospinal fluid (CSF) shows a lymphocytic pleocytosis — typically 100 to 200 white cells per microliter, predominantly lymphocytes rather than neutrophils — along with an elevated protein and a normal glucose. This triad is shared with viral meningitis, but in summer months in an endemic area with a co-existing cranial nerve palsy or radicular pain, Lyme rockets up the differential.

Kids are more likely than adults to present with meningitis as their leading symptom, often combined with a facial palsy on the same admission.

Painful Radiculoneuritis (Bannwarth Syndrome)

Bannwarth syndrome is the European signature of Lyme. In the U.S. it is rare; in central and northern Europe it is one of the two most common neurologic presentations (alongside meningitis). The classic description:

Bannwarth is frequently misdiagnosed as disc disease — a pinched nerve from a herniated lumbar or cervical disc. Patients are sent for MRIs, given muscle relaxants, even offered epidural injections, while the real culprit is a treatable infection. In endemic regions, clinicians commonly order a Lyme blood test (serology) for severe night-predominant radicular pain with no clear mechanical trigger.

Late-Stage Encephalomyelitis

This is the rarest and most serious form — parenchymal invasion, meaning Borrelia inflames the brain and spinal cord tissue itself, not just their coverings. It is almost exclusively a European phenomenon, tied to B. garinii, and it typically appears months to years after an untreated infection.

Features include white-matter lesions on magnetic resonance imaging (MRI) that can mimic multiple sclerosis, spastic paraparesis (stiff, weak legs with brisk reflexes), bladder dysfunction, and cognitive changes that go beyond "brain fog" into measurable deficits on formal testing. It is one of the few Lyme presentations that reliably requires intravenous antibiotics.

Lyme Encephalopathy

Lyme encephalopathy is a more controversial category than the ones above. Patients describe subtle but real cognitive complaints: memory lapses, word-finding difficulty, slowed processing, concentration problems, sometimes mood changes. These symptoms are real — but they do not always come with abnormal cerebrospinal fluid, abnormal imaging, or clear evidence of active Borrelia in the nervous system.

Much of what is called Lyme encephalopathy in the literature ends up overlapping with post-treatment Lyme disease syndrome (PTLDS) — the cluster of persistent fatigue, pain, and cognitive symptoms that can follow an otherwise well-treated infection (see the PTLDS article). Whether the mechanism is lingering low-grade infection, immune dysregulation, or a post-infectious autonomic/neurologic syndrome remains genuinely debated. What is not debated by mainstream infectious-disease physicians is that long courses of repeat antibiotics do not help and carry real harm.

Peripheral Neuropathy

A minority of Lyme patients develop a mild distal sensory neuropathy: tingling, numbness, or burning in the feet and hands, sometimes with patchy areas of altered sensation. Nerve-conduction studies may show a mild axonal pattern. A less common variant is mononeuritis multiplex — individual peripheral nerves picked off one at a time, producing asymmetric weakness or sensory loss in a patchwork distribution.

Peripheral neuropathy from Lyme usually improves with standard antibiotic treatment, though recovery is slower than for cranial neuropathies because peripheral nerves regenerate at only about a millimeter per day.

Diagnostic Workup

Neuroborreliosis is diagnosed through a combination of clinical picture, blood serology, and — when indicated — cerebrospinal fluid analysis.

When a Lumbar Puncture Is and Is Not Done

A lumbar puncture (LP, also called a spinal tap) is generally done when:

An LP is generally not considered necessary for an isolated unilateral Bell's palsy with mild symptoms in an endemic area. The usual approach in that scenario is a serum serology, oral doxycycline started before the result returns, and follow-up; the reasoning is that a spinal tap to confirm an infection already being treated rarely changes the plan.

Treatment — Intravenous vs Oral

For decades the reflex answer to "Lyme in the nervous system" was intravenous (IV) ceftriaxone 2 g once daily for 14 to 21 days, usually through a peripherally inserted central catheter (PICC line) with home-infusion nursing. That approach still works, but it is no longer the only — or even the preferred — option for most patients.

A series of European randomized controlled trials, most notably Ljøstad et al. (2008) in Lancet Neurology, demonstrated that oral doxycycline 200 mg per day for 14 days was just as effective as intravenous ceftriaxone for European neuroborreliosis, including Bannwarth syndrome and meningitis. In that Norwegian double-blind trial of 118 adults, doxycycline 200 mg or ceftriaxone 2 g was given once a day for 14 days; 4 months later the symptom score had improved by 4.5 points with doxycycline and 4.4 points with ceftriaxone, and 48% versus 33% had recovered completely, a difference that was not statistically significant. The 2010 European Federation of Neurological Societies (EFNS) guideline rates the evidence at its top level (level A) that oral doxycycline (200 mg daily) and intravenous ceftriaxone (2 g daily) are equally effective when symptoms are confined to the peripheral nervous system, including meningitis. The 2020 guidelines of the Infectious Diseases Society of America, American Academy of Neurology and American College of Rheumatology (IDSA/AAN/ACR) (Lantos et al.) explicitly endorse oral doxycycline as equivalent for most neuroborreliosis presentations.

Two later trials added to this. A 2021 Finnish randomized trial of 210 adults with suspected neuroborreliosis (Kortela 2021) compared oral doxycycline 100 mg twice daily for 4 weeks with intravenous ceftriaxone 2 g daily for 3 weeks; both groups improved equally on a 0–10 symptom scale at 12 months (a change of −3.9 versus −3.8 points). A 2022 Norwegian double-blind, placebo-controlled trial of 121 patients (Solheim 2022) compared doxycycline 200 mg once daily for 2 weeks with the same dose for 6 weeks; there were no treatment failures and no serious side effects, the groups did not differ at 10 weeks or 12 months, and the authors concluded that their results strongly indicate no benefit of doxycycline beyond 2 weeks (although, on the trial's formal statistical test, non-inferiority could not be established).

The regimens described in the guidelines and these trials:

See the antibiotic treatment protocols article for full dosing, pediatric adjustments, and allergy workarounds.

Bell's Palsy Specifically

Lyme-associated Bell's palsy deserves a focused note because it is so common and because patients naturally ask: "Do I also need prednisone?"

In idiopathic (non-Lyme) Bell's palsy, a short prednisone taper started within 72 hours clearly improves recovery. Whether the same is true for Lyme-associated facial palsy is genuinely unresolved. The 2020 IDSA/AAN/ACR guideline makes no recommendation on adding corticosteroids to antibiotics for Lyme facial palsy and calls it a knowledge gap; it notes that some small studies suggested benefit while others raised the possibility of harm. While the cause of an acute facial palsy is still uncertain, the same guideline recommends corticosteroids within 72 hours, as for idiopathic Bell's palsy, and treats stopping or starting them once Lyme is confirmed as a matter of patient preference and clinical judgment.

Two recent studies found no effect either way. In the United States series of 44 patients (Marques 2022), 24 of the 38 treated patients with complete follow-up received corticosteroids along with antibiotics; complete recovery at 12 months and time to recovery did not differ between those who did and did not. In a Swedish study of 57 adults compared with earlier patients (Avellan 2021), lasting weakness remained in 7% of those given prednisolone 60 mg daily for 5 days (then tapered over 5 days) with doxycycline, versus 20% of earlier patients given doxycycline alone, a difference that was not statistically significant; the authors concluded that corticosteroids neither improve nor impair the outcome.

Most clinicians in endemic areas take a pragmatic middle path: start doxycycline, and also give a short prednisone taper (commonly 60 mg for 5 days, then a rapid taper), on the reasoning that if the diagnosis turns out to be idiopathic they have covered that too, and if it is Lyme the antibiotic handles the infection.

The prognosis is good. Roughly 80–90% of Lyme-associated Bell's palsy recovers fully over weeks to months; in the Marques series, 34 of 38 treated patients recovered completely, 3 nearly completely and 1 was left with moderate weakness. A minority are left with mild residual weakness, asymmetry when smiling, or subtle synkinesis (the eye twitches when the mouth moves). Eye care during the acute phase protects the cornea while the lid will not close; the usual measures are artificial tears by day and lubricating ointment with a patch or taped lid at night.

Recovery Timeline

Realistic expectations help enormously. Typical patterns:

Residual Symptoms After Treatment

Even after a complete, guideline-concordant course of antibiotics, a meaningful minority of patients continue to report fatigue, cognitive complaints, and intermittent pains for weeks to months. This is common enough that it has its own name: post-treatment Lyme disease syndrome. Read the PTLDS article for a full discussion.

Two points matter here. First, residual symptoms do not automatically mean the antibiotics failed or that Borrelia is still active. Multiple high-quality randomized trials have shown that prolonged or repeat antibiotic courses do not produce sustained improvement and do cause real harm (Clostridium difficile colitis, PICC-line infections, gallstones from ceftriaxone). Second, the absence of a quick antibiotic fix does not mean you are dismissed. Graded exercise, sleep restoration, targeted treatment of pain and mood symptoms, and patience are the real tools. Most patients continue to improve over 6–12 months.

Red Flags Requiring the ER

Most neuroborreliosis can be worked up in an outpatient clinic. The following scenarios warrant same-day emergency evaluation:

Lyme is a treatable infection. Catching neurologic involvement early, treating with the right antibiotic at the right dose, and giving your nervous system time to heal will resolve symptoms completely for the great majority of patients. A droopy face is not a death sentence, a splitting headache is not a stroke, and a night of radicular pain is not a disc you need surgery for — it is, more often than people realize, a bacterial infection that a two-week prescription will put right.

Key Research Papers

  1. Halperin JJ, Shapiro ED, Logigian E, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology [RETIRED]. Neurology. 2007;69(1):91–102. — PubMed PMID: 17522387 (Retired guidance, superseded by the 2020 IDSA/AAN/ACR guideline.)
  2. Dattwyler RJ, Luft BJ, Kunkel MJ, et al. Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease. N Engl J Med. 1997;337(5):289–294. — doi:10.1056/NEJM199707313370501 (Intravenous ceftriaxone vs oral doxycycline in acute disseminated Lyme disease without meningitis; 133 of 140 patients had multiple erythema migrans rashes. Not a neuroborreliosis trial.)
  3. Ljøstad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7(8):690–695. — PubMed PMID: 18567539
  4. Lantos PM, et al. Clinical Practice Guidelines by the IDSA, AAN, and ACR: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Clin Infect Dis. 2021;72(1):e1–e48. — doi:10.1093/cid/ciaa1215
  5. Mygland A, Ljøstad U, Fingerle V, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17(1):8–16, e1–4. — PubMed PMID: 19930447
  6. Kortela E, Kanerva MJ, Puustinen J, et al. Oral Doxycycline Compared to Intravenous Ceftriaxone in the Treatment of Lyme Neuroborreliosis: A Multicenter, Equivalence, Randomized, Open-label Trial. Clin Infect Dis. 2021;72(8):1323–1331. — PubMed PMID: 32133487
  7. Solheim AM, Lorentzen ÅR, Dahlberg AO, et al. Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial. J Neurol Neurosurg Psychiatry. 2022;93(11):1222–1228. — PubMed PMID: 35896378
  8. Marques A, Okpali G, Liepshutz K, Ortega-Villa AM. Characteristics and outcome of facial nerve palsy from Lyme neuroborreliosis in the United States. Ann Clin Transl Neurol. 2022;9(1):41–49. — PubMed PMID: 35064770
  9. Avellan S, Bremell D. Adjunctive Corticosteroids for Lyme Neuroborreliosis Peripheral Facial Palsy-A Prospective Study With Historical Controls. Clin Infect Dis. 2021;73(7):1211–1215. — PubMed PMID: 33905494

PubMed Topic Searches

For further reading, the following PubMed topic searches return current peer-reviewed work on neuroborreliosis diagnosis, treatment, and outcomes:

  1. PubMed: Lyme neuroborreliosis treatment
  2. PubMed: Bannwarth syndrome
  3. PubMed: Facial palsy and Lyme disease
  4. PubMed: Ljøstad doxycycline neuroborreliosis trial
  5. PubMed: Lyme meningitis and CSF antibody index
  6. PubMed: Borrelia garinii neurotropism
  7. PubMed: Lyme encephalopathy and cognitive symptoms
  8. PubMed: Bilateral facial palsy and Lyme disease

Back to Table of Contents

Connections

Back to Table of Contents